AX CAPITAL Strengthens Dubai Real Estate Leadership with Exclusive Peace Homes Collaboration
Photo Courtesy of AX CAPITAL
DUBAI, United Arab Emirates, May 26, 2025 (GLOBE NEWSWIRE) — AX CAPITAL , a leading real estate brokerage in Dubai, has entered an exclusive partnership with Peace Homes to market and sell two distinguished developments: Natuzzi Harmony and Sky Vista. This collaboration highlights the confidence top developers place in AX CAPITAL's proven track record in connecting exceptional properties with discerning global buyers.
This is not the first experience of AX CAPITAL cooperation with leading Dubai developers as an exclusive sales partner. AX CAPITAL's portfolio already includes more than 10 exclusive projects that have been successfully sold through the agency, including ultra-luxury branded residences.
With a sophisticated marketing ecosystem, AX CAPITAL is strategically positioned to attract high-quality leads through targeted digital campaigns, data-driven outreach, and a keen understanding of buyer behaviour. The firm's globally connected Primary Sales team, ensures maximum exposure for Natuzzi Harmony and Sky Vista, engaging serious investors from around the world.
As AX CAPITAL leads the sales efforts for Natuzzi Harmony and Sky Vista, investors gain access to the UAE's renowned tax-free investment environment. The absence of personal income tax and capital gains tax, coupled with zero withholding tax on dividends and interest, makes the UAE a prime location for real estate investment.
With a legacy of over 14,000 completed transactions and a portfolio of more than 7,000 properties, AX CAPITAL helps clients leverage the UAE's favourable tax policies, even as the country introduces a 9% corporate tax rate on income exceeding AED 375,000—one of the lowest globally.
AX CAPITAL specializes in identifying prime investment opportunities within the UAE's free zones, where 100% foreign ownership and tax exemptions are available. The firm's in-depth expertise across 40+ free zones empowers clients to structure their holdings for maximum tax efficiency, including benefiting from a 0% corporate tax on qualifying income.
Additionally, AX CAPITAL guides clients in utilizing the UAE's network of over 140 Double Taxation Agreements (DTAs), ensuring investors enjoy tax certainty and protection. The firm offers end-to-end support, from navigating complex regulatory frameworks to securing long-term residency through the 10-year Golden Visa program.
About AX CAPITAL
Founded in 2019, AX CAPITAL has swiftly established itself as Dubai's fastest-growing real estate agency. With a team of over 700 multilingual specialists fluent in more than 30 languages, the firm serves a diverse clientele across 100+ nationalities, delivering exceptional service and expertise across the UAE's real estate market.
About Peace Homes Development
Since its establishment in 2013, Peace Homes Development has been synonymous with affordable luxury, blending innovative architectural design with community-focused living. With 14 completed towers and six ongoing mega-developments spanning 4.2 million square feet of residential space, Peace Homes exemplifies its commitment to 'democratizing opulence,' highlighted by signature features such as private pools in all residences in Sky Vista and Natuzzi Harmony.
Contact Information
Nicoline EngerMarketing Executive AssistantAX CAPITAL+971 52 235 2553
[email protected]
https://www.axcapital.ae/
Dubai, UAE
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Associated Press
22 minutes ago
- Associated Press
Digital Course Assistant Launches AI Tools Membership for Course Creators
Black Mountain, NC, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Course creators, meet your new secret weapon. Digital Course Assistant, an AI-powered membership designed specifically for online course creators, is launching on August 21, 2025 — and it's here to take the stress out of course building, content creation, and marketing. Course creators, meet your new secret weapon. With its growing suite of plug-and-play AI assistants, Digital Course Assistant helps creators launch faster, market better, and stress less — even if they're not tech-savvy. 'Our mission is to empower course creators by giving them access to powerful, easy-to-use AI tools that eliminate overwhelm and save hours every week,' said Julie Ball, Founder of Digital Course Assistant. 'We believe creators should spend less time stuck in tasks and more time doing what they love.' To support the launch, Ball also hosts the Digital Course Assistant Podcast, a bite-sized show that explores smarter marketing strategies, time-saving tools, and AI-powered shortcuts for course creators. Built for solopreneurs and small teams, the membership makes it possible to accomplish more without hiring — helping course creators scale faster, simplify their workflow, and reduce the stress of doing it all alone. The platform is packed with custom-built AI tools that handle everything from writing sales pages and emails to planning course modules and refining brand voice. Unlike generic AI platforms, every assistant inside DCA is trained specifically for modern course businesses — making it easy to get high-quality results in minutes, not hours. Early subscribers can join the waitlist now to be the first to experience what's next in the digital course industry. To learn more or join the waitlist, visit Digital Course Assistant: Launch faster. Market better. Stress less. About Digital Course Assistant Founded by entrepreneur and course creation expert Julie Ball, Digital Course Assistant is an AI-powered membership designed to help online course creators simplify their workflow, speed up content creation, and scale with less stress. With a growing suite of plug-and-play AI tools, the platform empowers solopreneurs and small teams to accomplish more—without hiring or tech overwhelm. Digital Course Assistant is on a mission to make modern marketing and course building easier, smarter, and more accessible for creators at every stage. Media Contact Julie Ball, Founder [email protected] Available for interviews, features, and podcast appearances. A video accompanying this announcement is available at
Yahoo
an hour ago
- Yahoo
CBD Pouches Market to Hit Valuation of US$ 535.62 Million By 2033
CBD pouches market is currently defined by a surge in consumer demand for convenient, smoke-free wellness products. Innovation in flavors and precise, moderate dosages are attracting a broader, health-conscious demographic, solidifying its mainstream appeal. Chicago, Aug. 11, 2025 (GLOBE NEWSWIRE) -- The global CBD pouches market was valued at US$ 90.12 million in 2024 and is expected to reach US$ 535.62 million by 2033, growing at a CAGR of 21.9% during the forecast period 2025–2033. The market is maturing rapidly, driven by specific consumer preferences and strategic product positioning. The dominance of the 10-20 mg dosage illustrates a consumer base that is increasingly educated, seeking tangible wellness benefits without overwhelming effects. This segment has become the core of the CBD pouches market by successfully bridging the gap between cautious new users and experienced consumers. The preference for flavored options underscores the importance of the user experience; by removing the barrier of unpleasant taste, brands have made CBD consumption more accessible and enjoyable, integrating it into daily routines as a lifestyle product rather than a purely medicinal one. This is a key growth engine for the entire market. Download Sample Pages: The resilience of offline retail channels in the CBD pouches market speaks volumes about the consumer's need for trust and immediacy in this sector. In an industry still navigating complex regulations, the ability to interact with a product and a knowledgeable salesperson provides a level of assurance that online platforms struggle to match. Physical stores serve as crucial educational hubs, building consumer confidence and fostering loyalty through direct engagement. Looking ahead, the synergy between these dominant segments—a trusted, palatable product at an effective dose, available in a reliable retail environment—will continue to define the growth trajectory of the industry. Key Findings in CBD Pouches Market Market Forecast (2033) US$ 535.62 million CAGR 21.9% Largest Region (2024) North America (59%) By Content 10-20mg (52%) By Type Flavored (88%) By Distribution Offline (68%) Top Drivers Increasing consumer awareness of CBD's potential health and wellness benefits. Growing demand for smokeless and discreet alternatives to conventional tobacco. Progressive legalization of cannabis products, increasing accessibility and social acceptance. Top Trends Rising interest in microdosing and low-dose CBD product formulations. Enhanced focus on product transparency through third-party lab testing results. Innovation in formulations to include functional ingredients beyond just CBD. Top Challenges Navigating the complex and often inconsistent legal and regulatory landscape. Strict advertising and marketing restrictions imposed by major online platforms. High market competition and content saturation for key search terms. U.S. Hemp Production Forms a Robust Market Foundation The viability of the CBD pouches market is fundamentally tied to its agricultural backbone. In 2024, the United States saw 45,294 acres of industrial hemp planted in the open. Of this, a total of 32,694 acres were harvested. Data from 8,153 surveyed hemp producers reveals a highly specialized cultivation landscape. Floral hemp, the primary source for CBD, accounted for 20.8 million pounds produced from 11,827 harvested acres. This reflects a significant yield increase of 669 pounds per acre compared to the previous year, with an average yield of 1,757 pounds per acre. In parallel, production under protection (e.g., greenhouses) utilized 3.52 million square feet, yielding 356,000 clones and transplants, 49,420 pounds of floral hemp, and 2,364 pounds of seed hemp. Other segments included fiber hemp, with 60.4 million pounds produced from 18,855 acres at an average yield of 3,205 pounds per acre. Grain hemp production stood at 3.41 million pounds from 4,863 acres, while seed hemp production in the open yielded 697,000 pounds from 2,160 acres. Unpacking the Economic Realities of Raw Material Pricing The total value of U.S. hemp production in 2024 reached an impressive $445 million. This was comprised of $417 million from hemp grown in the open and $28.7 million from crops under protection. Floral hemp was the most valuable segment at $386 million, followed by seed hemp at $16.9 million, fiber hemp at $11.2 million, and grain hemp at $2.62 million. These values translate into specific wholesale costs that shape the final price within the CBD pouches market. In 2024, CBD biomass costs ranged from a low of $8.50 to a high of $230 per pound. Farmers often received $150 per pound for machine-trimmed outdoor CBD flower, while premium indoor-grown flower commanded an average of $600 per pound. For biomass with a 10% CBD content, the rate was $3.00 per pound. Looking ahead, Q2 2025 price projections per metric ton of hemp are $3,998 in the USA, $1,330 in China, $3,417 in Germany, and $3,210 in the Middle East, highlighting global cost differentials. Product Innovation and Composition Define Competitive Edges Product differentiation is a critical success factor in the competitive CBD pouches market. Market leader Cannadips exemplifies this trend with a standard tin containing 15 pouches, each with 10mg of water-dispersible CBD for a total of 150mg. Their 5x strength line significantly increases potency to 50mg of CBD per pouch, totaling 750mg per tin. Across these lines, the company offers a combined 8 flavors, including American Spice and Tropical Mango. Competitor Chill CBD Pouches offers products with a potency of 10-15mg per pouch. This innovation is happening within regulatory guardrails; for instance, French regulations in 2024 mandated a daily consumption limit of 50mg of CBD per person, a key constraint for product formulation in that region. The diversity of strength and flavor profiles underscores the industry's response to varied consumer demands. Corporate Strategy and Market Expansion Drive Brand Growth Strategic expansion is a dominant theme in the CBD pouches market as companies seek to establish a broader footprint. In a landmark move outside its home state, Cannadips announced in November 2024 its entry into the Arkansas market. This move expands its reach beyond the 6,000 stores where its hemp pouches are already available. Other cannabis-related companies are also expanding, with Aurora Cannabis acquiring MedReleaf Australia in February 2024 and Curaleaf acquiring Northern Green Canada in May 2024 to bolster international operations. New entrants are also making waves; Juana Dips, launched in 2024, already sold its cannabis pouches in 2 states (Colorado and Massachusetts) as of early 2025 and was in licensing talks with 13 companies in other states to rapidly scale its brand presence. Navigating the Complex and Shifting Global Regulatory Maze The regulatory environment remains a pivotal and fluid element influencing the CBD pouches market. In the U.S., the FDA Commissioner testified before a House committee on April 11, 2024, reaffirming the agency's position on needing a new regulatory pathway for CBD products. Progress is being made, as in June 2025, the FDA received 2 public comments supporting the addition of a "cannabinoid hemp product" category to its safety reporting system. In Europe, Switzerland introduced a new tobacco law in October 2024 that also governs industrial hemp flowers. Meanwhile, a February 2024 bill signed into law legalized medical cannabis in Ukraine, opening a new market. Conversely, Italy imposed significant restrictions on "cannabis light" in 2024 and, via a decree on June 27, 2024, classified CBD as a narcotic medicinal substance, creating substantial market hurdles. Clinical Research and Scientific Inquiry Bolster Consumer Trust Credibility and consumer trust are being built through rigorous scientific validation. A significant multicenter trial in India with 178 participants, with results reported in 2024, assessed an oral CBD solution for anxiety. Further research from a 2021 clinical trial involving 8 weeks of daily CBD use showed potential for enhancing natural killer cells. In 2025, a UCSD clinical trial studying CBD for early psychosis remains active, with plans to randomize approximately 120 patients. Demonstrating the ongoing effort to understand the substance, a study with 6 healthy adults characterized the urinary pharmacokinetic profile of 100-mg oral and vaporized CBD, with its proceedings published in October 2024. This growing body of clinical evidence is crucial for the long-term mainstream acceptance of the CBD pouches market. A Surge in Innovation and Intellectual Property Filings The future of the CBD pouches market is being written in its patent filings. A systematic review published in May 2025, which initially retrieved 99 patents filed between 2012 and 2024, ultimately included 15 relevant patents on cannabis drug delivery systems, highlighting the pace of innovation. Specific to the pouch format, a patent application for a "Cannabinoid pouch" was published on July 18, 2024. Another key filing, patent application WO2025116961A1 for cannabis compositions and oral products, is cited for 2025, indicating future product pipelines. These filings demonstrate a clear industry trend toward protecting novel formulations and delivery technologies, which will serve as a key competitive differentiator and barrier to entry in the coming years. Expanding Retail Footprints and Strategic Distribution Channels Accessibility is key to market growth, and distribution channels are widening significantly. In a pivotal move in 2024, pharmacies in France were authorized to sell CBD-based food supplements, opening a trusted and mainstream retail avenue. Trade shows remain a vital platform for brand visibility. Cannadips showcased its products at the 2024 InterTabac Trade Fair in Dortmund, Germany, from September 19-21. The company occupied booth number A29 in hall number 6, demonstrating a strategic investment in reaching European distributors and retailers. This expansion into both pharmaceutical and international trade channels is essential for moving CBD pouches from specialty items to everyday consumer goods, directly fueling growth in the CBD pouches market. Need a Customized Version? Request It Now: A Dynamic Competitive Landscape and International Opportunities The competitive field is intensifying with a mix of established and new players. An August 2025 report identified 11 key players in the U.S. market, including Cannadips, VELO CBD, and FlowBlend. A separate August 2024 report profiled 10 major players, among them METOLIUS HEMP COMPANY and Canndid. The launch of new companies like Juana Dips in 2024 indicates a healthy and growing ecosystem. This competition is unfolding on a global stage with distinct international rules. For instance, following 2024 legal changes, adults in Malta can possess 7 grams of cannabis and cultivate 4 plants, though public consumption carries a 500 Euro fine. As of April 2024, Switzerland has an updated enforcement aid for CBD, and product approvals for the entire bloc of 27 EU member states are under review, creating a complex but opportunity-rich international CBD pouches market. Global CBD Pouches Market Major Players: Comp9 Canndid Chillbar FlowBlend Cannadips Vibe CBD+CBG Jake's Mint Chew Nicopods ehf. V&YOU Metolius Hemp Company Key Market Segmentation: By Type Flavored Unflavored By Content Up to 10 mg 10 mg-20 mg Others By Distribution Channel Online Offline By Region North America Europe Asia Pacific Middle East & Africa South America Need a Detailed Walkthrough of the Report? Request a Live Session: About Astute Analytica Astute Analytica is a global market research and advisory firm providing data-driven insights across industries such as technology, healthcare, chemicals, semiconductors, FMCG, and more. We publish multiple reports daily, equipping businesses with the intelligence they need to navigate market trends, emerging opportunities, competitive landscapes, and technological advancements. With a team of experienced business analysts, economists, and industry experts, we deliver accurate, in-depth, and actionable research tailored to meet the strategic needs of our clients. At Astute Analytica, our clients come first, and we are committed to delivering cost-effective, high-value research solutions that drive success in an evolving marketplace. Contact Us:Astute AnalyticaPhone: +1-888 429 6757 (US Toll Free); +91-0120- 4483891 (Rest of the World)For Sales Enquiries: sales@ Follow us on: LinkedIn | Twitter | YouTube CONTACT: Contact Us: Astute Analytica Phone: +1-888 429 6757 (US Toll Free); +91-0120- 4483891 (Rest of the World) For Sales Enquiries: sales@ Website:
Yahoo
2 hours ago
- Yahoo
AI in Healthcare RCM Market Size to Attain USD 180.33 Billion by 2034, Growing at 24.20% CAGR
The global AI in healthcare revenue cycle management market is valued at USD 25.7 billion in 2025 and is projected to surge to approximately USD 180.33 billion by 2034, registering a robust CAGR of 24.20% during the forecast period. Ottawa, Aug. 11, 2025 (GLOBE NEWSWIRE) -- According to a study published by Towards Healthcare, a sister firm of Precedence Research, the global AI in healthcare revenue cycle management market was valued at USD 20.68 billion in 2024 and is projected to reach approximately USD 180.33 billion by 2034, expanding at a CAGR of 24.20%. The growth of the market is driven by the growing need for automation to optimize and reduce risks, which fuels the growth of the market. The Complete Study is Now Available for Immediate Access | Download the Sample Pages of this Report @ Key Takeaways North America dominated the AI in healthcare revenue cycle management market share in 2024. Asia-Pacific is expected to grow at the highest CAGR in the market during the forecast period. By component, the software segment held the major market revenue share in 2024. By component, the services segment is expected to grow at the fastest CAGR in the market during the studied years. By type, the integrated AI-RCM platforms segment held the largest market share. By type, the standalone AI-RCM tools segment is expected to grow at the fastest CAGR in the market during the studied years. By deployment mode, the cloud/web-based segment led the AI in healthcare revenue cycle management market in 2024. By deployment mode, the cloud-based deployment segment is expected to grow at the fastest CAGR in the market during the studied years. By application, the claims & denials management segment held the largest revenue share market in 2024. By application, the eligibility and benefits verification segment is expected to grow at the fastest CAGR in the market during the studied years. By end-user, the hospitals and health systems segment dominated the revenue market share in 2024. What is the Growth Potential Responsible for the Growth of AI in healthcare revenue cycle management market? AI in healthcare revenue cycle management involves using artificial intelligence to automate and enhance billing, coding, claims processing, and payment activities, leading to more accurate and efficient healthcare financial operations. The market for AI in healthcare revenue cycle management is growing rapidly as providers look for smarter, more effective ways to manage complex administrative tasks. AI is employed to automate medical coding, identify billing errors, forecast claim denials, and expedite payment collections. Integrating AI with electronic health records and cloud platforms improves real-time data processing and decision-making. Consequently, healthcare organizations are increasing cash flow, lowering costs, and achieving higher accuracy in financial management. The AI in healthcare revenue cycle management (RCM) market expands as providers adopt AI to optimize billing, coding, and claims workflows. AI reduces human errors, decreases claim denials, and accelerates reimbursements, enhancing financial performance. The need for real-time data insights, automated processes, and healthcare predictive analytics drives the adoption of AI-powered RCM solutions. This transition promotes greater efficiency and accuracy in handling complex healthcare administrative and financial activities. You can place an order or ask any questions, please feel free to contact us at sales@ What are the Growing Trends Associated with AI in healthcare revenue cycle management market? Automation of Routine Tasks: Integration of AI for automation reduces manual efforts and errors, which influences the adoption of the market. Increased Focus on Data Quality and Security: With increased reliance on AI for ensuring data accuracy and security to maintain patient trust and regulatory compliance, it fuels growth. Improved Claim Processing and Denial Management: AI-powered systems help and enable proactive correction, and reducing lost revenue fuels the growth of the market. What is the Growing Challenge in AI in healthcare revenue cycle management market? The key growth challenge that hinders the growth of the market is the data security and privacy for the protection of sensitive patient data for implementing AI-powered solution, which is crucial and limits the growth. The integration with legacy systems, training, and change management needs proper training and support, which limits the growth and hinders the expansion of the market. Regional Analysis How did North America Dominate the market in 2024? North America dominated the AI in healthcare revenue cycle management market share in 2024, early AI adoption, and high healthcare spending. The region benefits from strong government support for digital health, widespread electronic health records, and a focus on reducing administrative costs. The presence of key industry players and ongoing investments in AI-driven revenue cycle management (RCM) solutions further reinforce North America's leadership. Rapid growth is driven by rising healthcare costs and increasingly complex billing and reimbursement processes. Providers are adopting AI to automate tasks, minimize errors, and enhance claim accuracy. The extensive use of cloud-based RCM platforms facilitates scalable and real-time AI integration. Regulatory shifts and a move toward value-based care also boost demand for advanced data analytics and predictive tools, propelling the region's AI-powered RCM market. The AI in healthcare revenue cycle management market in the U.S. is expanding rapidly due to increasing healthcare costs, digital transformation, and regulatory complexities. Hospitals and providers are investing in advanced RCM solutions to improve billing accuracy, reduce denials, and enhance cash flow. Outsourcing and AI integration are also driving growth in this sector. Canada's healthcare revenue cycle management market is growing steadily as healthcare institutions seek greater efficiency and transparency. Rising demand for digital health solutions and government initiatives to streamline operations are key drivers. RCM tools help manage complex billing processes, especially in private clinics and specialized practices outside the publicly funded healthcare system. What has caused Asia Pacific's significant growth in the AI healthcare revenue cycle management market in 2024? Asia-Pacific is expected to grow at the highest CAGR in the AI in healthcare revenue cycle management market during the forecast period, fueled by rapid digital transformation, expanding infrastructure, and increasing healthcare expenditures. Governments are actively promoting healthcare modernization and the adoption of electronic health records. The growing middle class, heightened demand for efficient billing systems, and the rising popularity of telehealth services are fueling demand for AI-driven RCM solutions, further accelerating market growth. The market expansion is also supported by increasing digital health adoption, initiatives like the National Digital Health Mission, and the widespread use of EHR and cloud-based systems. Healthcare providers use AI to automate claims processing, reduce denials, and improve billing accuracy. The surge in telehealth and support from health tech startups is additionally accelerating the deployment of AI-powered RCM solutions, enhancing efficiency and financial performance across the sector. China's healthcare RCM sector is witnessing strong growth amid healthcare reforms and increasing patient volumes. The shift toward digital medical records, expanding private healthcare, and the need for efficient billing systems drive demand. Local and global vendors are investing in AI and cloud-based RCM technologies to address inefficiencies and regulatory compliance challenges. India's growing private healthcare sector fuels demand for effective revenue cycle management solutions. Fragmented billing processes, rising insurance adoption, and medical tourism contribute to RCM adoption. Hospitals and clinics increasingly embrace digital platforms and outsourcing to improve revenue collection, reduce administrative burden, and ensure accurate claim processing in a complex ecosystem. Get the latest insights on life science industry segmentation with our Annual Membership: Segmental Insights By Component How Did Software Segment Dominated the AI In Healthcare Revenue Cycle Management Market In 2024? The software segment held the major market revenue share in 2024, primarily because of its capacity to automate intricate billing, coding, and claims processes. Healthcare providers increasingly adopted AI-driven software for real-time analytics, denial management, and seamless integration with EHR systems. Its scalability, ease of updates, and ability to reduce administrative workload made it the preferred option, driving substantial revenue growth and reinforcing its market dominance. The services segment is expected to grow at the fastest CAGR in the market during the studied years. This segment is experiencing rapid expansion as healthcare organizations seek expert support to optimize AI-enabled revenue cycle tools. Providers rely on these services not just for installation but also for system optimization, compliance assistance, and ongoing performance monitoring. The complexity of AI integration and the need for customized solutions across diverse healthcare environments fuel demand, making this the fastest-growing segment in the AI healthcare RCM market. By Type Which type of Segment Dominated the AI in Healthcare Revenue Cycle Management Market in 2024? The integrated AI-RCM platforms segment held the largest market share. Owing to its ability to unify various revenue cycle processes within a single system, eliminating the need for multiple disconnected tools. This integrated approach enhances coordination, data accuracy, and decision speed. Healthcare providers favor these platforms for their flexibility, scalability, and ability to support seamless departmental interactions, ultimately improving cash flow and financial outcomes. The standalone AI-RCM tools segment is expected to grow at the fastest CAGR in the market during the studied years. Many healthcare providers prefer specialized tools that address specific issues like claim denials or payment delays. These solutions are quicker to deploy, require less integration effort, and deliver targeted results. Their capacity to improve workflows without necessitating a full system overhaul makes them especially appealing to organizations with limited resources or phased digital strategies. By Deployment Mode How Did Cloud/Web-Based Type Segment Dominated the AI In Healthcare Revenue Cycle Management Market In 2024? The cloud/web-based segment led the AI in healthcare revenue cycle management market in 2024, as providers increasingly prioritized solutions offering real-time data access, automatic updates, and lower initial costs. These platforms support remote operations, simplify compliance with evolving regulations, and decrease reliance on in-house IT. Their ability to adapt swiftly to changing workflows and scale with organizational needs made them the preferred deployment choice for hospitals and clinics seeking operational efficiency and agility. The cloud-based deployment segment is expected to grow at the fastest CAGR in the market during the studied years, driven by its support for dynamic healthcare environments with minimal upfront investments. It allows providers to adopt AI tools without complex hardware, offering scalable, centralized access to financial data. As organizations emphasize digital agility and remote capabilities, cloud solutions are becoming essential for streamlining revenue cycle management, reducing downtime, and enabling faster decision-making. Become a valued research partner with us - By Application Which Application Segment Dominated the AI In Healthcare Revenue Cycle Management Market In 2024? The claims & denials management segment held the largest revenue share market in 2024, due to the increasing burden of administrative tasks and high claim rejection rates. Healthcare providers need AI solutions that can detect errors early, streamline appeals, and predict denial risks, improving efficiency and accuracy to maintain steady revenue flow. The eligibility and benefits verification segment is expected to grow at the fastest CAGR in the market during the studied years as healthcare providers strive to improve front-end accuracy and reduce billing issues downstream. Automating these checks through AI minimizes manual effort, speeds up claim processing, and results in cleaner claims, thus expediting reimbursements. By End User How Did Hospitals and Health Systems Segment Dominated the AI In Healthcare Revenue Cycle Management Market In 2024? The hospitals and health systems segment dominated the revenue market share in 2024. Their extensive administrative needs and requirement for comprehensive financial solutions to manage diverse services and payer contracts have driven higher adoption of AI-enabled RCM tools. With better access to funding and infrastructure, these organizations are well-positioned to implement advanced technologies, cementing their leadership in this market segment. Recent Developments In May 2025, Infinx acquired the healthcare RCM division of i3 Verticals to strengthen its market reach and tech capabilities. The move supports Infinx's goal to integrate scalable solutions and expert services across the revenue cycle, helping healthcare providers improve overall financial performance. In June 2024, Adonis secured $31 million to scale its AI-driven revenue cycle automation platform. The solution supports over 35 EHR systems and clearinghouses, offering a versatile and adaptable tool for various healthcare providers. Top Companies and Their Contributions to the Market Company Contributions to AI in Healthcare RCM AGS Health, LLC Leverages AI and automation to enhance coding, billing, and denial management. Offers analytics-driven insights for improved RCM outcomes. AdvantEdge Healthcare Solutions, Inc Provides AI-powered revenue cycle tools for specialty practices. Focuses on claim optimization and reducing denials. CareCloud Integrates AI in its cloud-based platform to streamline scheduling, billing, and collections for faster reimbursements. Conifer Health Solutions Uses AI to optimize financial performance, automate workflows, and personalize patient financial experiences. McKesson Corporation Implements AI-driven analytics in RCM to reduce errors, manage claims, and support data-driven financial decisions. The SSI Group Inc Offers AI-based clearinghouse solutions to automate claims management and improve reimbursement efficiency. Athenahealth Employs machine learning in its RCM suite to enhance billing accuracy, predict denials, and accelerate payments. Change Healthcare Pioneers AI tools for claims editing, denial prediction, and payment integrity across healthcare networks. R1 RCM Integrates AI across the RCM lifecycle to reduce administrative costs, improve patient engagement, and boost revenue yield. GE HealthCare Applies AI and analytics in RCM to support hospital operations, enhance cash flow, and improve financial visibility. Browse More Insights of Towards Healthcare: The global healthcare data synthesis tools market is witnessing strong momentum, with revenue expected to climb significantly over the forecast period from 2025 to 2034, potentially reaching several hundred million dollars. The global healthcare supply chain management market was valued at USD 3.24 billion in 2024, is expected to reach USD 3.6 billion in 2025, and is projected to grow to approximately USD 9.2 billion by 2034, registering a CAGR of 11.05% between 2025 and 2034. The global digital healthcare education market stood at USD 53.67 billion in 2024, increased to USD 58.2 billion in 2025, and is forecast to reach around USD 120.67 billion by 2034, expanding at a CAGR of 8.44% during the forecast period. The global advanced healthcare solutions market is evolving rapidly and is poised for notable revenue growth from 2025 to 2034. The global mixed reality in healthcare market was valued at USD 1.27 billion in 2024, is set to grow to USD 1.89 billion in 2025, and is expected to reach approximately USD 67.45 billion by 2034, reflecting a robust CAGR of 48.74% between 2025 and 2034. The global healthcare cybersecurity market stood at USD 20.56 billion in 2024, rose to USD 24.39 billion in 2025, and is projected to reach about USD 112.6 billion by 2034, growing at a CAGR of 18.54% over the forecast years. The global big data in healthcare market was valued at USD 93.07 billion in 2024, reached USD 110.97 billion in 2025, and is anticipated to climb to USD 540.77 billion by 2034, expanding at a CAGR of 19.24% between 2025 and 2034. The global healthcare cold chain logistics market was worth USD 59.97 billion in 2024, grew to USD 65.14 billion in 2025, and is forecast to reach USD 137.13 billion by 2034, advancing at a CAGR of 8.63% during the forecast period. The global big data analytics in healthcare market was valued at USD 40.61 billion in 2024, increased to USD 47.42 billion in 2025, and is expected to reach approximately USD 190.98 billion by 2034, recording a CAGR of 16.73% between 2025 and 2034. The global healthcare contract research organization (CRO) market stood at USD 53.87 billion in 2024, rose to USD 57.66 billion in 2025, and is projected to reach USD 106.25 billion by 2034, expanding at a CAGR of 7.04% during the forecast period. Top Companies in the AI in Healthcare Revenue Cycle Management Market AGS Health, LLC AdvantEdge Healthcare Solutions, Inc CareCloud Conifer Health Solutions McKesson Corporation The SSI Group Inc Athenahealth Change Healthcare R1 RCM GE HealthCare Oracle Segments Covered in the Report By Component Software Services By Type Integrated AI-RCM Platforms Standalone AI-RCM Tools By Deployment Mode Cloud / Web-Based Cloud-Based Deployment On-Premise By Application Claims & Denials Management Eligibility & Benefits Verification By End User Hospitals & Health Systems Others By Region North America U.S. Canada Mexico Europe UK Germany France Italy Spain Sweden Denmark Norway Asia Pacific Japan Chin India Australia Thailand South Korea Latin America Brazil Argentina MEA South Africa Saudi Arabia UAE Kuwait Immediate Delivery Available | Buy This Premium Research @ Access our exclusive, data-rich dashboard dedicated to the healthcare market - built specifically for decision-makers, strategists, and industry leaders. The dashboard features comprehensive statistical data, segment-wise market breakdowns, regional performance shares, detailed company profiles, annual updates, and much more. From market sizing to competitive intelligence, this powerful tool is one-stop solution to your gateway Access the Dashboard: About Us Towards Healthcare is a leading global provider of technological solutions, clinical research services, and advanced analytics, with a strong emphasis on life science research. Dedicated to advancing innovation in the life sciences sector, we build strategic partnerships that generate actionable insights and transformative breakthroughs. As a global strategy consulting firm, we empower life science leaders to gain a competitive edge, drive research excellence, and accelerate sustainable growth. You can place an order or ask any questions, please feel free to contact us at sales@ Europe Region - +44 778 256 0738 North America Region - +1 8044 4193 44 Web: Find us on social platforms: LinkedIn | Twitter | InstagramError in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
